4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-22-016372
CEO and CFO bought 4,500 shares at $10.90 ($49,050)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2022-06-09 | Purchase | +4,500 | $10.90 | $49,050 | 1,243,453 | D |
| Open-market purchases · 4,500 sh · avg $10.90 · $49,050 | |||||||
Loading xslF345X03/ownership.xml…